FDA panel backs Pfizer’s low-dose COVID-19 vaccine for children
WASHINGTON (AP) — The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as government advisers…
Tag: fda
COVID-19 vaccines for ages 5 to 11 could be ready as soon as next week
WASHINGTON — The next wave of the massive COVID-19 vaccination campaign could begin as soon as next week, after federal regulators…
CDC panel backs expanded COVID-19 booster rollout
WASHINGTON (AP) — Millions more Americans are closer to getting a COVID-19 booster as influential government advisers endorsed on Thursday…
In quiet debut, Alzheimer’s drug finds questions, skepticism
The first new Alzheimer’s treatment in more than 20 years was hailed as a breakthrough when regulators approved it more…
FDA panel endorses booster shot for J&J COVID-19 vaccine
WASHINGTON (AP) — U.S. health advisers endorsed a booster of Johnson & Johnson’s COVID-19 vaccine Friday, citing concern that Americans…
Fauci says trick-or-treating this year is fine
WASHINGTON – The government’s top infectious diseases expert says families can feel safe trick-or-treating outdoors this year for Halloween as…
Pfizer vaccine for children ages 5-11 may be available in November
WASHINGTON (AP) — Pfizer has submitted research to the U.S. Food and Drug Administration on the effectiveness of its COVID-19…
Medication abortion becomes latest GOP target
Medication abortion accounts for about 40% of all abortions in the U.S. The increasingly common method relies on pills rather…
COVID-19 vaccine works in children ages 5-11, Pfizer reports
Pfizer said Monday that its COVID-19 vaccine works for children ages 5 to 11 and that it will seek U.S.…
FDA grants full approval to Pfizer’s COVID-19 shot, now known as ‘Comirnaty’
WASHINGTON — The U.S. has its first fully approved vaccine against COVID-19, with federal health officials announcing Monday the approval of Pfizer-BioNTech’s…
COVID vaccines likely to get FDA’s full OK within weeks, Fauci hopes
WILMINGTON, Del. (AP) — The U.S. government’s top infectious disease expert, Dr. Anthony Fauci, said Sunday that he was hopeful…
Pfizer to discuss vaccine booster with U.S. officials
WASHINGTON (AP) — Pfizer says it plans to meet with top U.S. health officials Monday to discuss the drugmaker’s request…
FDA trims use of contentious Alzheimer’s drug amid backlash
WASHINGTON (AP) — A month after approving a controversial new Alzheimer’s drug, U.S. health regulators on signed off Thursday on…
Alzheimer’s drug stirs hope for patients, worry for doctors
In the weeks since a new Alzheimer’s drug was approved, hopeful patients have bombarded Dr. Alireza Atri with calls and…
Half of U.S. cosmetics contain toxic chemicals, study finds
WASHINGTON (AP) — More than half the cosmetics sold in the United States and Canada are awash with a toxic…
Medicare copays for new Alzheimer’s drug could reach $11,500
WASHINGTON (AP) — A new $56,000-a-year Alzheimer’s drug would raise Medicare premiums broadly, and some patients who are prescribed the…